Chinese biotech shares are surging this year on growing optimism over innovative cancer treatments being licensed to western ...

This is an audio transcript of the FT News Briefing podcast episode: ‘Big Pharma markets left in a ‘patent cliff’-hanger’ ...

However, yesterday’s shock twist out of Washington could test just how tough Big Pharma really is, with health care stocks ...

Today’s settlement brings in millions of dollars to help Utah heal from this epidemic and ensures families see the justice ...

AstraZeneca’s $1.3 billion bet on CinCor Pharma and its mid-phase hypertension drug baxdrostat seems to have paid off based ...

In 2024-25, the government has disbursed a total of Rs 10,114 crore. PLI firms in the electronics sector received Rs 5,732 ...

The pharmaceutical industry is staring down a major patent cliff, with key drugs from Merck (MRK), Bristol Myers Squibb (BMY), and Johnson & Johnson (JNJ) set to lose exclusivity by 2030. Yahoo ...

Novartis made one of the biggest investments in Cannes among pharma companies, sending approximately 20 people from the organization to the creativity festival. They came with multiple goals, ...

Nurix Therapeutics shows strong BTK degrader data and key pharma ties, with risks but solid long-term potential. Find out why ...

The inhaler manufacturer has earmarked five acres next to its existing headquarters in Holmes Chapel for new buildings to support its growth and net zero aspirations.

The firms lead an investment valuing PCI Pharma at $10 billion, see the company benefiting from broader trends.

Yahoo Finance Senior Reporter Anjalee Khemlani joins Morning Brief to discuss Merck's (MRK) pending $10 billion acquisition ...